fbpx

National Advertising Division Says Pre-Launch Investor Presentation Can Be Challenged Under Advertising LawBy: David Bernsteinon January 12, 2021 at 5:15 pm Publication: IPWatchdog.com | Patents & Patent Law

It has long been a fundamental tenet of advertising law that comments made to investors, and particularly those made before the commercial launch of a product or service, do not constitute the kind of “advertising” that is regulated by the Federal Trade Commission (FTC) or the National Advertisi  Read More>>

Categories   Business, Government, Guest Contributors, IP News, IPWatchdog Articles, Trademark, advertising law, Bayer HealthCare, Better Business Bureau, false advertising, Federal Trade Commission, Lanham Act, National Advertising Division, PLx Pharma, Vazalore

YouTube
LinkedIn
LinkedIn
Share